DE69636112D1 - Verfahren zum testen von myocarditis und cardiomyopathie - Google Patents

Verfahren zum testen von myocarditis und cardiomyopathie

Info

Publication number
DE69636112D1
DE69636112D1 DE69636112T DE69636112T DE69636112D1 DE 69636112 D1 DE69636112 D1 DE 69636112D1 DE 69636112 T DE69636112 T DE 69636112T DE 69636112 T DE69636112 T DE 69636112T DE 69636112 D1 DE69636112 D1 DE 69636112D1
Authority
DE
Germany
Prior art keywords
myocarditis
cardiomyopathy
testing
testing myocarditis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69636112T
Other languages
English (en)
Other versions
DE69636112T2 (de
Inventor
Akira Matsumori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Publication of DE69636112D1 publication Critical patent/DE69636112D1/de
Application granted granted Critical
Publication of DE69636112T2 publication Critical patent/DE69636112T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69636112T 1995-08-30 1996-08-30 Verfahren zum testen von myocarditis und cardiomyopathie Expired - Fee Related DE69636112T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP22222495 1995-08-30
JP22222495 1995-08-30
PCT/JP1996/002437 WO1997007820A1 (fr) 1995-08-30 1996-08-30 Remede destine aux maladies cardiaques

Publications (2)

Publication Number Publication Date
DE69636112D1 true DE69636112D1 (de) 2006-06-14
DE69636112T2 DE69636112T2 (de) 2006-12-14

Family

ID=16779073

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69636112T Expired - Fee Related DE69636112T2 (de) 1995-08-30 1996-08-30 Verfahren zum testen von myocarditis und cardiomyopathie

Country Status (6)

Country Link
US (1) US6214535B1 (de)
EP (1) EP0790062B1 (de)
JP (1) JP3104257B2 (de)
CA (1) CA2203377A1 (de)
DE (1) DE69636112T2 (de)
WO (1) WO1997007820A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739313A (en) * 1995-11-13 1998-04-14 Regents Of The University Of Minnesota Radionuclide labeling of vitamin B12 and coenzymes thereof
EP1023901A4 (de) * 1997-10-13 2004-10-27 Otsuka Pharma Co Ltd Heilmittel für hepatitis c und dessen verwendung
US6187304B1 (en) * 1998-04-02 2001-02-13 Genentech, Inc. Effects of IFN-γ on cardiac hypertrophy
US6806363B1 (en) * 1999-04-16 2004-10-19 Mayo Foundation For Medical Education & Research Cobalamin conjugates useful as antitumor agents
US7591995B2 (en) * 1999-10-15 2009-09-22 Mayo Foundation For Medical Education And Research Cobalamin conjugates useful as imaging and therapeutic agents
EP1334114A2 (de) * 2000-10-25 2003-08-13 Mayo Foundation For Medical Education And Research Transcobalamin-bindende konjugate zur behandlung abnormaler zellulärer proliferation
JP2005508332A (ja) * 2001-09-28 2005-03-31 メイオウ・フアウンデーシヨン・フオー・メデイカル・エジユケイシヨン・アンド・リサーチ 薬剤を送達するための、輸送タンパク質とコンジュゲートコバラミンとの同時投与
WO2005120540A2 (en) * 2004-06-09 2005-12-22 Schering Aktiengesellschaft Interferon alpha or beta for treatment of cardiomyopathy and endothelial dysfunction
KR101542063B1 (ko) * 2014-04-25 2015-08-05 (주) 영남메탈 내화커버를 구비한 파이프 커플러

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244543B1 (de) * 1973-07-27 1977-07-01 Inst Nl Sante Rech Medica
CS215108B2 (en) * 1977-07-15 1982-07-30 Wellcome Found Method of making the interferrone
JPS5564799A (en) * 1978-11-07 1980-05-15 Toray Ind Inc Multi-stage concentration and purification of interferon originated from human fibroblast
US4241174A (en) * 1978-11-24 1980-12-23 Hoffmann-La Roche Inc. Interferon assay
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
US5622848A (en) * 1990-05-23 1997-04-22 Medical Discoveries, Inc. Electrically hydrolyzed salines as microbiocides for in vitro treatment of contaminated fluids containing blood
US5372808A (en) * 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
US5464020A (en) * 1991-03-25 1995-11-07 Lerner; Albert M. Diagnosing and treating subacute cardiac dysfunction
TW263437B (de) * 1992-09-24 1995-11-21 Takeda Pharm Industry Co Ltd
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome

Also Published As

Publication number Publication date
US6214535B1 (en) 2001-04-10
DE69636112T2 (de) 2006-12-14
EP0790062A4 (de) 1999-06-16
EP0790062B1 (de) 2006-05-10
CA2203377A1 (en) 1997-03-06
EP0790062A1 (de) 1997-08-20
WO1997007820A1 (fr) 1997-03-06
JP3104257B2 (ja) 2000-10-30

Similar Documents

Publication Publication Date Title
DE69508921T2 (de) Verfahren zum nachweis von staphylokokken
DE59705043D1 (de) Verfahren zum Sortieren von Versandstücken
DE69832068D1 (de) Verfahren und apparat zum generieren von kenngrössen
DE69827066D1 (de) Verfahren und Vorrichtung zum Kompensieren von Mehrkanalechos
DE69826583D1 (de) Vorrichtung und Verfahren zum Erreichen von klinischen wichtigen Analytverhältnissen
DE69528807T2 (de) Verfahren und Vorrichtung zum Entdecken von Antwortgeräten
DE69533028D1 (de) Vorrichtung und verfahren zum multiplexen von signalen
DE69634459D1 (de) Verfahren und Anordnung zum Vergleichen von strukturierten Dokumenten
DE69633771D1 (de) Verfahren und gerät zum kontaktieren
DE69637620D1 (de) Verfahren und zusammensetzung zum nachweis der bak
DE69942385D1 (de) Verfahren und Gerät zur Auswahl von Kompilierarten während der Laufzeit
DE69732255D1 (de) Verfahren und vorrichtungen zum nachweis von bakteriophagen
DE69628883D1 (de) Gerät und Verfahren zum Kollationieren von Mustern
DE69534506D1 (de) Verfahren und Gerät zum Bestimmen von Tonbereichsgrenzen
DE69635547D1 (de) Verfahren und einrichtung zum wiegen von kombinationen
DE69605590D1 (de) Verfahren zum Nachweis von Protein und Kit dafür
DE69607971T2 (de) Verfahren zum sortieren von materialstücken
DE69621448T2 (de) Wärmerückstellbarer gegenstand und verfahren zum dichten von kabelverbindungen
DE69626897D1 (de) Verfahren und Vorrichtung zum teilweisen Färben von Garnen
DE69522828D1 (de) Verfahren zum entmetallieren von raffinerieeizätzen
DE59611332D1 (de) Verfahren und System zum Erkennen von Isolationsfehlern
DE69636112D1 (de) Verfahren zum testen von myocarditis und cardiomyopathie
DE69629540D1 (de) Verfahren und Gerät zum Sortieren von Elementen
DE69828246D1 (de) Gerät und Verfahren zum Entwickeln von Bildern
ATE196378T1 (de) Vorrichtung und verfahren zum prüfen von münzen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee